Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí chiến sự Iran của Mỹ vượt 47 tỷ USD

Chi phí chiến sự Iran của Mỹ vượt 47 tỷ USD

Thế giới
(Baothanhhoa.vn) - Dữ liệu mới nhất từ Lầu Năm Góc tính đến ngày 16/10 cho thấy chi phí quân sự của Mỹ trong cuộc chiến với Iran đã vượt mốc 47 tỷ USD, trong đó phần lớn ngân sách được dùng vào việc thay thế các loại đạn dược và khí tài đã tiêu hao.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh